CAR-T Therapy for Refractory Autoimmune Diseases

NCT07059169 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

LiangZou